394 related articles for article (PubMed ID: 14748750)
1. Trends in peptic ulcer pharmacotherapy.
Sivri B
Fundam Clin Pharmacol; 2004 Feb; 18(1):23-31. PubMed ID: 14748750
[TBL] [Abstract][Full Text] [Related]
2. Peptic-ulcer disease.
Chan FK; Leung WK
Lancet; 2002 Sep; 360(9337):933-41. PubMed ID: 12354485
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
Graham DY
Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
[TBL] [Abstract][Full Text] [Related]
4. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
5. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
[TBL] [Abstract][Full Text] [Related]
6. Management of NSAID-associated peptic ulcer disease.
Melcarne L; García-Iglesias P; Calvet X
Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):723-33. PubMed ID: 26775657
[TBL] [Abstract][Full Text] [Related]
7. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
8. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
9. [Peptic ulcer disease etiology, diagnosis and treatment].
Bak-Romaniszyn L; Wojtuń S; Gil J; Płaneta-Małecka I
Pol Merkur Lekarski; 2004; 17 Suppl 1():128-32. PubMed ID: 15603370
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
[TBL] [Abstract][Full Text] [Related]
11. Critical issues in the pathophysiology and management of peptic ulcer disease.
Hunt RH; Malfertheiner P; Yeomans ND; Hawkey CJ; Howden CW
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):685-99. PubMed ID: 8590166
[TBL] [Abstract][Full Text] [Related]
12. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
Lanas A; Remacha B; Sáinz R; Hirschowitz BI
Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of lansoprazole against peptic ulcers induced by non-steroidal anti-inflammatory drugs: endoscopic evaluation of ulcer healing.
Matsukawa Y; Tomita Y; Nishinarita S; Horie T; Kato K; Arakawa Y; Ko K; Shimada H; Nakano M; Kitami Y; Kurosaka H
J Int Med Res; 1997; 25(4):190-5. PubMed ID: 9283991
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based clinical practice guidelines for peptic ulcer disease 2015.
Satoh K; Yoshino J; Akamatsu T; Itoh T; Kato M; Kamada T; Takagi A; Chiba T; Nomura S; Mizokami Y; Murakami K; Sakamoto C; Hiraishi H; Ichinose M; Uemura N; Goto H; Joh T; Miwa H; Sugano K; Shimosegawa T
J Gastroenterol; 2016 Mar; 51(3):177-94. PubMed ID: 26879862
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand.
Graham DY
Am J Gastroenterol; 1996 Oct; 91(10):2080-6. PubMed ID: 8855725
[TBL] [Abstract][Full Text] [Related]
16. [PATIENT WITH PEPTIC ULCER DISEASE].
Quadranti NR; Diminić-Lisica I; Marković NB; Popović B
Acta Med Croatica; 2015 Nov; 69(4):287-91. PubMed ID: 29083839
[TBL] [Abstract][Full Text] [Related]
17. [Peptic ulcer: facts and questions -- 2010].
Hagymási K; Tulassay Z
Orv Hetil; 2010 Jun; 151(26):1054-61. PubMed ID: 20558352
[TBL] [Abstract][Full Text] [Related]
18. An etiologic approach to management of duodenal and gastric ulcers.
Rex DK
J Fam Pract; 1994 Jan; 38(1):60-7. PubMed ID: 8289053
[TBL] [Abstract][Full Text] [Related]
19. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
[TBL] [Abstract][Full Text] [Related]
20. Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.
Ji KY; Hu FL
World J Gastroenterol; 2006 Jun; 12(24):3789-92. PubMed ID: 16804960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
